(62 days)
No
The summary describes a standard immunoassay system and reagents, with no mention of AI or ML technologies. The term "Intellicheck" is mentioned in the intended use, but this is likely a proprietary system feature related to quality control or system checks, not necessarily AI/ML.
No
The device quantitatively measures vitamin B12 concentration to aid in the diagnosis of anemia, which is a diagnostic purpose, not a therapeutic one.
Yes
The 'Intended Use / Indications for Use' section explicitly states that the device "quantitatively measures vitamin B12 concentration in human serum and plasma... to aid in the diagnosis of anemia". This clearly indicates its role in disease diagnosis.
No
The device description explicitly states that the system is comprised of three main elements, including "The VITROS Immunodiagnostic System instrumentation," which is a hardware component. The submission also describes reagent packs and calibrators, which are physical components.
Yes, this device is an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use explicitly states that the device "quantitatively measures vitamin B12 concentration in human serum and plasma... to aid in the diagnosis of anemia." This clearly indicates that the device is used to examine specimens derived from the human body (serum and plasma) for the purpose of providing information for the diagnosis of a disease (anemia).
- Device Description: The description details the components used to perform an "immunoassay" on "human body fluids." Immunoassays are a common type of in vitro diagnostic test.
- Predicate Device: The predicate device listed (BECKMAN Access Vitamin B12 assay) is also an IVD, which further supports the classification of this device as an IVD.
The information provided aligns perfectly with the definition of an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
1 & 2. The VITROS Immunodiagnostic Products Vitamin B12 Reagent Pack 1/2 and the VITROS Immunodiagnostic Products Vitamin B12/ Folate Reagent Pack 3 quantitatively measures vitamin B12 concentration in human serum and plasma (EDTA or heparin), to aid in the diagnosis of anemia using the VITROS ECi Immunodiagnostic System with Intellicheck.
- The VITROS Immunodiagnostic Products Vitamin B12 Calibrators- for use in the calibration of the Vitros Immunodiagnostic System for the quantitative measurement of vitamin B12 in human serum and plasma (EDTA or heparin).
Product codes
CDD, JIS
Device Description
The VITROS Immunodiagnostic System uses luminescence as the signal in the quantitative and semi-quantitative determination of selected analytes in human body fluids, commonly serum and plasma. Coated microwells are used as the solid phase separation system.
The system is comprised of three main elements:
- The VITROS Immunodiagnostic Products range of immunoassay products (in this case VITROS Immunodiagnostic Products Vitamin B12 Reagent Pack 1/ 2, VITROS Immunodiagnostic Products Vitamin B12/ Folate Reagent Pack 3, Vitros Immunodiagnostic Products Vitamin B12 Calibrators, which are combined by the VITROS Immunodiagnostic System to perform the VITROS Vitamin B12 assay.
- The VITROS Immunodiagnostic System instrumentation, which provides automated use of the immunoassay kits. The VITROS Immunodiagnostic System was cleared for market by a separate 510(k) premarket notification (K962919).
- Common reagents used by the VITROS System in each assay. The VITROS Immunodiagnostic Products Signal Reagent and VITROS Immunodiagnostic Products Universal Wash Reagent were cleared as part of the VITROS Immunodiagnostic Products Total T3 Reagent Pack and VITROS Immunodiagnostic Products Total T3 Calibrators 510(k) premarket notification (K964310).
The VITROS System and common reagents are dedicated specifically for use only with the VITROS Immunodiagnostic Products range of immunoassay products.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The relationship between the VITROS Vitamin B12 assay and the predicate device, determined by Deming's Regression, is:
VITROS Vitamin B12 assay = 1.028 x X - 9.34 (pg/mL), with a correlation coefficient of 0.943, where X is BECKMAN Access Vitamin B12 Assay.
This relationship was determined from a panel of patient samples from a variety of clinical categories.
In addition to the above mentioned correlation study, studies were performed to determine the precision, analytical sensitivity, specificity and expected values of the VITROS Vitamin B12 assay, (refer to the VITROS Vitamin B12 Assay Test Methodology Sheet for summaries of the results of these studies).
Equivalence was demonstrated using currently commercially available reagents along with patient samples covering a variety of clinical categories.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
correlation coefficient of 0.943
Predicate Device(s)
Reference Device(s)
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 862.1810 Vitamin B
12 test system.(a)
Identification. A vitamin B12 test system is a device intended to measure vitamin B12 in serum, plasma, and urine. Measurements obtained by this device are used in the diagnosis and treatment of anemias of gastrointestinal malabsorption.(b)
Classification. Class II.
0
JAN 2 4 2002
Chapter 1 - Summary Information
510(k) Summary
:
This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR 807.92.
The assigned 510(k) number is: KO13899
- Submitter Ortho-Clinical Diagnostics, Inc. name, 100 Indigo Creek Drive address, Rochester, New York 14626-5101 contact (716) 453-4041
Contact Person: Marlene A. Shulman
-
- Preparation Date 510(k) prepared: November 20, 2001 date
- Trade or Proprietary Name: 3. Device name VITROS Immunodiagnostic Products Vitamin B12 Assay VITROS Immunodiagnostic Products Vitamin B12 Calibrators
Common Name: Vitamin B12 assay Classification Name: Vitamin B12 test system (862.1810)
The VITROS Immunodiagnostic Products Vitamin B12 Assay is substantially 4. Predicate device equivalent to the BECKMAN Access Vitamin B12 assay (K933142).
Continued on next page
VITROS Immunodiagnostic Products Vitamin B12 Assay
1
-
The VITROS Immunodiagnostic System uses luminescence as the signal in 5. Device the quantitative and semi-quantitative determination of selected analytes in description human body fluids, commonly serum and plasma. Coated microwells are used as the solid phase separation system.
The system is comprised of three main elements: -
- The VITROS Immunodiagnostic Products range of immunoassay products (in this case VITROS Immunodiagnostic Products Vitamin B12 Reagent Pack 1/ 2, VITROS Immunodiagnostic Products Vitamin B12/ Folate Reagent Pack 3, Vitros Immunodiagnostic Products Vitamin B12 Calibrators, which are combined by the VITROS Immunodiagnostic System to perform the VITROS Vitamin B12 assay.
-
- The VITROS Immunodiagnostic System instrumentation, which provides automated use of the immunoassay kits. The VITROS Immunodiagnostic System was cleared for market by a separate 510(k) premarket notification (K962919).
-
- Common reagents used by the VITROS System in each assay. The VITROS Immunodiagnostic Products Signal Reagent and VITROS Immunodiagnostic Products Universal Wash Reagent were cleared as part of the VITROS Immunodiagnostic Products Total T3 Reagent Pack and VITROS Immunodiagnostic Products Total T3 Calibrators 510(k) premarket notification (K964310).
The VITROS System and common reagents are dedicated specifically for use only with the VITROS Immunodiagnostic Products range of immunoassay products.
Continued on next page
2
- The VITROS Immunodiagnostic Products Vitamin B12 Reagent Pack 1/ 2 6. Device and the VITROS Immunodiagnostic Products Vitamin B12/ Folate Reagent intended Pack 3 quantitatively measures vitamin B12 concentration in human serum use and plasma (EDTA or heparin), to aid in the diagnosis of anemia using the VITROS ECi Immunodiagnostic System with Intellicheck.
- The VITROS Immunodiagnostic Products Vitamin B12 Assay is 7. Comparison substantially equivalent to the BECKMAN Access Vitamin B12 assay to predicate (predicate device) which was cleared by the FDA (K933142) for IVD use. device
The relationship between the VITROS Vitamin B12 assay and the predicate device, determined by Deming's Regression, is:
VITROS Vitamin B12 assay = 1.028 x X - 9.34 (pg/mL), with a correlation coefficient of 0.943, where X is BECKMAN Access Vitamin B12 Assay.
This relationship was determined from a panel of patient samples from a variety of clinical categories.
In addition to the above mentioned correlation study, studies were performed to determine the precision, analytical sensitivity, specificity and expected values of the VITROS Vitamin B12 assay, (refer to the VITROS Vitamin B12 Assay Test Methodology Sheet for summaries of the results of these studies).
Table 1 lists the characteristics of the assays performed using the VITROS Vitamin B12 assay and the BECKMAN Access Vitamin B12 assay.
Continued on next page
3
-
- Comparison Table 1 to predicate device,
Continued
- Comparison Table 1 to predicate device,
| Device
Characteristic | VITROS Vitamin B12
assay | Predicate Device |
|------------------------------------|-------------------------------------------------------------------------|----------------------------------------------------------------|
| Calibration range | 0-1000 pg/mL | 0-1500 pg/mL |
| Basic principle | Solid phase immunoassay | Solid phase immunoassay |
| Tracer | Enzyme labeled | Enzyme-labeled |
| Binding Protein | Porcine Intrinsic Factor-
biotinylated intrinsic
factor conjugate | Porcine Intrinsic Factor-
alkaline phosphotase
conjugate |
| Instrumentation | VITROS
Immunodiagnostic
System | BECKMAN Access
Immunoassay System |
| Sample type | Serum and plasma
(EDTA or heparin). | Serum and plasma
(heparin). |
| Sample volume | 30μL | 45μL |
| Incubation time and
temperature | 48 minutes at 37°C | 30 minutes at 36.5 °C |
Continued on next page
4
The data presented in the pre-market notification demonstrate that the 8. Conclusions performance of the VITROS Vitamin B12 assay is substantially equivalent to the cleared predicate device.
Equivalence was demonstrated using currently commercially available reagents along with patient samples covering a variety of clinical categories.
The data presented in the premarket notification provide a reasonable assurance that the VITROS Vitamin B12 assay is safe and effective for the stated intended use.
5
Image /page/5/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized caduceus symbol, which is often associated with healthcare. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the symbol.
Food and Drug Administration 2098 Gaither Road Rockville MD 20850
Ms. Marlene A. Shulman Regulatory Affairs Associate Ortho-Clinical Diagnostics, Inc. Regulatory Affairs MC00882 100 Indigo Creek Drive Rochester, NY 14626-5101
JAN 2 4 2002
Re: K013899
Trade/Device Names: Vitros Immunodiagnostic Products Vitamin B12 Reagent Pack1/2 Vitros Immunodiagnostic Products VitaminB12/ Folate Reagent Pack 3
Vitros Immunodiagnostic Products Vitamin B12 Calibrators Regulation Number: 21 CFR 862.1810; 21 CFR 862.1810; 21 CFR 862.1150 Regulation Name: Vitamin B12 test system; Vitamin B12 test system; Calibrator Regulatory Class: Class II; Class II; Class II Product Code: CDD; CDD; JIS Dated: November 21, 2001 Received: November 23, 2001
Dear Ms. Shulman:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
6
Page 2 -
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed nredicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4588. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/odrh/dsma/dsmamain.html".
Sincerely yours,
Steven Butman
Steven I. Gutman, M.D., M.B.A. Director Division of Clinical Laboratory-Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
7
Statement of Intended Use
| Page 1 of 1 | |
|---|---|
| 510(k) Number (if known): | K013899 |
| Device Name: | 1. VITROS Immunodiagnostic Products Vitamin B12 Reagent Pack 1/2 |
-
VITROS Immunodiagnostic Products Vitamin B12/ Folate Reagent Pack 3
-
VITROS Immunodiagnostic Products Vitamin B12 Calibrators |
| Indications for Use: | 1 & 2. The VITROS Immunodiagnostic Products Vitamin B12 Reagent Pack 1/2 and the VITROS Immunodiagnostic Products Vitamin B12/ Folate Reagent Pack 3 quantitatively measures vitamin B12 concentration in human serum and plasma (EDTA or heparin), to aid in the diagnosis of anemia using the VITROS ECi Immunodiagnostic System with Intellicheck. -
The VITROS Immunodiagnostic Products Vitamin B12 Calibrators- for use in the calibration of the Vitros Immunodiagnostic System for the quantitative measurement of vitamin B12 in human serum and plasma (EDTA or heparin). |
| | (PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF |
NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
| (Division Sign-Off) | |
|---|---|
| Division of Clinical Laboratory Devices | |
| 510(k) Number | K013899 |
| Prescription Use
| (Per 21 CFR 801.109) | OR | Over-The-Counter Use | ||
|---|---|---|---|---|
| ------------------------------------------ | -- | ---- | ---------------------- | -- |
(Optional Format 1-2-96)